A misconfigured MCP server provided complete access to a private equity firm’s data lake, illustrating the unique risks of AI adoption for specialized knowledge workers.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
